Australia markets closed

BioHarvest Sciences Inc. (8MV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1540+0.0010 (+0.65%)
At close: 08:18AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
12,672
12,672
5,498
2,102
396
Cost of revenue
7,039
7,039
4,279
1,432
258
Gross profit
5,633
5,633
1,219
670
138
Operating expenses
Research development
3,369
3,369
2,308
4,129
1,264
Selling general and administrative
12,074
12,074
9,352
4,759
4,314
Total operating expenses
15,599
15,599
11,831
9,161
6,304
Operating income or loss
-9,966
-9,966
-10,612
-8,491
-6,166
Interest expense
1,961
1,961
1,399
805
522
Total other income/expenses net
-501
-501
861
-484
-13
Income before tax
-12,564
-12,564
-11,236
-9,827
-6,584
Income from continuing operations
-12,564
-12,564
-11,236
-9,827
-6,584
Net income
-12,564
-12,564
-11,236
-9,827
-6,584
Net income available to common shareholders
-12,564
-12,564
-11,236
-9,827
-6,584
Basic EPS
-0.02
-0.03
-0.02
-0.02
-0.02
Diluted EPS
-0.02
-0.03
-0.02
-0.02
-0.02
Basic average shares
459,724
473,661
456,878
435,669
339,975
Diluted average shares
459,724
473,661
456,878
435,669
339,975